Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 3;32(7):420–422. [Article in Spanish] doi: 10.1016/S0212-6567(03)70760-4

El riesgo coronario en España y el tratamiento con fármacos hipolipemiantes

A Maiques Galán a,*, F Villar Álvarez b, C Llor Vila c, J Torcal Laguna d
PMCID: PMC7669119  PMID: 14622555

The content is available as a PDF (219.0 KB).

Footnotes

Los autores pertenecen al Grupo de PrevenciónCardiovascular del Programa de ActividadesPreventivas y Promoción de la Salud (PAPPS) de laSociedad Española de Medicina de Familia yComunitaria.

Bibliografía

  • 1.Sersa; Madrid: 1996. (Grupo de Prevención Cardiovascular del Programa de Actividades Preventivas y de Promoción de la Salud (PAPPS) de la Sociedad Española de Medicina de Familia y Comunitaria (semFYC). Guía de prevención cardiovascular). [Google Scholar]
  • 2.Villar Álvarez F., Maiques Galán A., Brotons Cuixart C., Torcal Laguna J., Lorenzo Piqueras J., Vilaseca Canals J. Prevención cardiovascular en atención primaria. Aten Primaria. 2001;28(Supl 2):13–27. [Google Scholar]
  • 3.Wood D., De Backe G., Faegerman O., Graham I., Mancia G., Pyörala K. Prevention of coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other societies on coronary prevention. Eur Heart J. 1998;19:1434–1503. doi: 10.1053/euhj.1998.1243. [DOI] [PubMed] [Google Scholar]
  • 4.Anderson K.M., Wilson P.W.F., Odell P.M., Kannel W.B. An update coronary risk profile. A statement for health professionals. Circulation. 1991;83:356–362. doi: 10.1161/01.cir.83.1.356. [DOI] [PubMed] [Google Scholar]
  • 5.Grundy S.M., Pasternak R., Greenland P., Smith S., Fuster V. Assessment of cardiovascular risk by use multiple-risk-factor assessment equations. A statement for health care professionals from the American Heart Association and American College of Caridology. J Am Coll Cardiol. 1999;34:1348–1359. doi: 10.1016/s0735-1097(99)00387-3. [DOI] [PubMed] [Google Scholar]
  • 6.Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III, or ATP III) Jama. 2001;285:2486–2497. doi: 10.1001/jama.285.19.2486. [DOI] [PubMed] [Google Scholar]
  • 7.Grundy S.M. Primary prevention of coronary heart disease. Integrating risk assessment with intervention. Circulation. 1999;100:988–998. doi: 10.1161/01.cir.100.9.988. [DOI] [PubMed] [Google Scholar]
  • 8.Marrugat J., Solanas P., D'Agostino R., Sullivan L., Ordovas J., Cordón F. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev Esp Cardiol. 2003;56:253–261. doi: 10.1016/s0300-8932(03)76861-4. [DOI] [PubMed] [Google Scholar]
  • 9.D'Agostino R.B., Sr., Grundy S., Sullivan L.M., Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a Multiple Ethnic Groups Investigation. J Am Med Assoc. 2001;286:180–187. doi: 10.1001/jama.286.2.180. [DOI] [PubMed] [Google Scholar]
  • 10.Marrugat J., Fiol M., Sala J., Tormo M.J., Segura A., Muñiz J. Variabilidad geográfica en España en las tasas de incidencia y mortalidad poblacionales por infarto agudo de miocardio en el estudio IBERICA. Gac Sanit. 2000;14(Supl 2):81. [Google Scholar]
  • 11.Masiá R., Pena A., Marrugat J., Sala J., Vila J., Pavesi High prevalencie of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. J Epidemiol Community Health. 1998;52:707–715. doi: 10.1136/jech.52.11.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Banegas J.R., Villar F., Pérez C., Jiménez R., Gil E., Muñiz J. Estudio epidemiológico de los factores de riesgo cardiovascular en la población española de 35 a 64 años. Rev San Hig Púb. 1993;67:419–445. [PubMed] [Google Scholar]
  • 13.Menotti A., Puddu P.E., Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur Heart J. 2000;21:365–370. doi: 10.1053/euhj.1999.1864. [DOI] [PubMed] [Google Scholar]
  • 14.Task Force of the European Society of Cardiology on Cardiovascular Mortality and Morbidity Statistic in Europe. The burden of cardiovascular disease mortality in Europe. Eur Heart J. 1997;18:1231–1248. [PubMed] [Google Scholar]
  • 15.Tunstall-Pedoe H., Kuulasmaa K., Mahonen M., Tolonen H., Ruokokoski E., Amouyel P. Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet. 1999;353:1547–1557. doi: 10.1016/s0140-6736(99)04021-0. [DOI] [PubMed] [Google Scholar]
  • 16.Instituto Nacional de Estadística; Madrid: 2001. (Instituto Nacional de Estadística. Defunciones según la causa de muerte 1998. Tomo I. Resultados básicos). [Google Scholar]
  • 17.Instituto Nacional de Estadística; Madrid: 2002. (Instituto Nacional de Estadística. Encuesta de morbilidad hospitalaria. Años 1989-1999). [Google Scholar]
  • 18.Conroy R.M., Pyörälä K., Fitzgerald A.P., Sans S., Menotti A., De Backer G. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987–1003. doi: 10.1016/s0195-668x(03)00114-3. [DOI] [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES